Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis I Soykan, B Sivri, I Sarosiek, B Kiernan, RW Mccallum Digestive diseases and sciences 43, 2398-2404, 1998 | 697 | 1998 |
Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings J Forster, I Damjanov, Z Lin, I Sarosiek, P Wetzel, RW McCallum Journal of Gastrointestinal Surgery 9, 102-108, 2005 | 365 | 2005 |
Gastric pacing is a new surgical treatment for gastroparesis J Forster, I Sarosiek, R Delcore, Z Lin, GS Raju, RW McCallum The American journal of surgery 182 (6), 676-681, 2001 | 249 | 2001 |
Gastric myoelectrical activity and gastric emptying in patients with functional dyspepsia Z Lin, EY Eaker, I Sarosiek, RW McCallum Official journal of the American College of Gastroenterology| ACG 94 (9 …, 1999 | 211 | 1999 |
Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation Z Lin, J Forster, I Sarosiek, RW McCallum Diabetes Care 27 (5), 1071-1076, 2004 | 206 | 2004 |
Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease I Soykan, I Sarosiek, J Shifflett, GF Wooten, RW McCallum Movement Disorders 12 (6), 952-957, 1997 | 197 | 1997 |
Gastric electrical stimulation improves outcomes of patients with gastroparesis for up to 10 years RW McCallum, Z Lin, J Forster, K Roeser, Q Hou, I Sarosiek Clinical Gastroenterology and Hepatology 9 (4), 314-319. e1, 2011 | 183 | 2011 |
Functional dyspepsia and gastroparesis in tertiary care are interchangeable syndromes with common clinical and pathologic features PJ Pasricha, M Grover, KP Yates, TL Abell, CE Bernard, KL Koch, ... Gastroenterology 160 (6), 2006-2017, 2021 | 170 | 2021 |
Clinical, psychiatric and manometric profile of cyclic vomiting syndrome in adults and response to tricyclic therapy1 F Namin, J Patel, Z Lin, I Sarosiek, P Foran, P Esmaeili, R McCallum Neurogastroenterology & Motility 19 (3), 196-202, 2007 | 170 | 2007 |
Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial HP Parkman, ML Van Natta, TL Abell, RW McCallum, I Sarosiek, ... Jama 310 (24), 2640-2649, 2013 | 168 | 2013 |
The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology I Sarosiek, KH Selover, LA Katz, JR Semler, GE Wilding, JM Lackner, ... Alimentary pharmacology & therapeutics 31 (2), 313-322, 2010 | 162 | 2010 |
Delayed gastric emptying in gastroesophageal reflux disease: reassessment with new methods and symptomatic correlations DC Buckles, I Sarosiek, RW McCallum, C McMillin The American journal of the medical sciences 327 (1), 1-4, 2004 | 154 | 2004 |
The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. I Soykan, I Sarosick, RW McCallum American Journal of Gastroenterology (Springer Nature) 92 (6), 1997 | 154 | 1997 |
Clinical response to gastric electrical stimulation in patients with postsurgical gastroparesis R McCallum, Z Lin, P Wetzel, I Sarosiek, J Forster Clinical Gastroenterology and Hepatology 3 (1), 49-54, 2005 | 137 | 2005 |
Safety and efficacy of ghrelin agonist TZP‐101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo‐controlled study N Ejskjaer, G Dimcevski, J Wo, PM Hellström, LC Gormsen, I Sarosiek, ... Neurogastroenterology & Motility 22 (10), 1069-e281, 2010 | 136 | 2010 |
Factors related to abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomiting WL Hasler, LA Wilson, HP Parkman, KL Koch, TL Abell, L Nguyen, ... Neurogastroenterology & Motility 25 (5), 427-e301, 2013 | 135 | 2013 |
Role of chronic cannabis use: cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome T Venkatesan, DJ Levinthal, BUK Li, SE Tarbell, KA Adams, RM Issenman, ... Neurogastroenterology & Motility 31, e13606, 2019 | 133 | 2019 |
Outcomes and factors associated with reduced symptoms in patients with gastroparesis PJ Pasricha, KP Yates, L Nguyen, J Clarke, TL Abell, G Farrugia, ... Gastroenterology 149 (7), 1762-1774. e4, 2015 | 133 | 2015 |
Mechanisms of symptomatic improvement after gastric electrical stimulation in gastroparetic patients RW McCallum, RW Dusing, I Sarosiek, J Cocjin, J Forster, Z Lin Neurogastroenterology & Motility 22 (2), 161-e51, 2010 | 131 | 2010 |
Aprepitant has mixed effects on nausea and reduces other symptoms in patients with gastroparesis and related disorders PJ Pasricha, KP Yates, I Sarosiek, RW McCallum, TL Abell, KL Koch, ... Gastroenterology 154 (1), 65-76. e11, 2018 | 130 | 2018 |